공지

정리해야할 것

밍거 2015. 11. 4. 23:15

Product별 originator/MoA/cost/name/

Cell line development - Sales Figure

Clinical Trials: CIOMS report vs. Safety Report

Regulations: 21 CFR part 11

Regulations: 351(k), 351(a) - Analytical 측면이 강화됨?

Others: 재무제표의 이해

IND application 세부사항

각 Product별 analysis법 정리